Dr. Binghe Xu is Professor and Director of the Department of Medical Oncology at the Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS), and Peking Union Medical College (PUMC) in Beijing, China. He received his Doctorate of Philosophy and Master of Science degree in oncology from the Peking Union Medical College, and his Doctorate of Medicine from Wuhan University Medical College, China.
His major interests are in basic and clinical research of solid tumors, especially breast cancer, as well as clinical trials of new anticancer agents. He has participated more than 60 clinical trials as PI. Currently, he is leading PI of several regional multicenter clinical trials and executive steering committee (EC) as well as steering committee (SC) members of several global clinical trials.
Dr. Xu has published 290 papers in peer reviewed oncology journals, including “Cancer Research”, “Journal of Clinical Oncology”, “Clinical Cancer Research”, “Lancet Oncology”, mainly with respect to breast diseases and clinical trials of anticancer agents.
Dr. Xu has served on the editorial boards of 20 journals including The International Journal of Biological Markers, Chinese Journal of Cancer Research.He is the associate editor of Translational Cancer Research and the several current society members, including: Chairman, Chinese Breast Cancer Society (CSBC); Member of American Society of Clinical Oncology (ASCO).